Details

Autor(en) / Beteiligte

• Terlizzi, V.
• Timpano, S.
• Salvi, M.
• Tosco, A.
• Castaldo, A.
• Fevola, C.
• Leonetti, G.
• Vitullo, P.
• Sepe, A.
• Badolato, R.
• Salvatore, D.

Titel

Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor

Ist Teil von

• Journal of cystic fibrosis, 2023-11, Vol.22 (6), p.1130-1132

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2023

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• •Gilbert's syndrome testing is needed for post-ETI hyperbilirubinemia.•ETI therapy is safe for Gilbert's syndrome-related hyperbilirubinemia.•More research is needed to understand causality and mechanisms.